health care

Correspondence on ‘Effectiveness of secukinumab versus an alternative TNF inhibitor in patients with axial spondyloarthritis previously exposed to TNF inhibitors in the Swiss Clinical Quality Management cohort’ by Micheroli et al
Jin-Xian Huang, Pui-Ying Leong, James Cheng-Chung Wei

Annals of the Rheumatic Diseases Sep 2020, annrheumdis-2020-218779; DOI: 10.1136/annrheumdis-2020-218779
Colchicine treatment in community healthcare setting to prevent severe COVID-19
Emanuel Della-Torre, Giuseppe A Ramirez, Lorenzo Dagna, Moreno Tresoldi

Annals of the Rheumatic Diseases Aug 2020, annrheumdis-2020-218759; DOI: 10.1136/annrheumdis-2020-218759
Hydroxychloroquine ineffective for COVID-19 prophylaxis in lupus and rheumatoid arthritis
Mendel E Singer, David C Kaelber, Maria J Antonelli

Annals of the Rheumatic Diseases Aug 2020, annrheumdis-2020-218500; DOI: 10.1136/annrheumdis-2020-218500
Tapering towards DMARD-free remission in established rheumatoid arthritis: 2-year results of the TARA trial
Elise van Mulligen, Angelique E Weel, J M Hazes, Annette van der Helm-van Mil, Pascal Hendrik Pieter de Jong

Annals of the Rheumatic Diseases Sep 2020, 79 (9) 1174-1181; DOI: 10.1136/annrheumdis-2020-217485
Response to: ‘Glucosamine and mortality: a note of caution’ by Conway
Zhi-Hao Li, Qing-Mei Huang, Wen-Fang Zhong, Xi-Ru Zhang, Chen Mao

Annals of the Rheumatic Diseases Aug 2020, annrheumdis-2020-218660; DOI: 10.1136/annrheumdis-2020-218660
COVID-19 outcomes in patients with systemic autoimmune diseases treated with immunomodulatory drugs
Khalil Ansarin, Ali Taghizadieh, Saeid Safiri, Aida Malek Mahdavi, Shirin Ranjbar, Soheil Teymouri, Masoud Ahangari Maleki, Alireza Khabbazi

Annals of the Rheumatic Diseases Aug 2020, annrheumdis-2020-218737; DOI: 10.1136/annrheumdis-2020-218737
Response to: ‘Women’s journey in Mexican rheumatology. Comment on ‘Gender gap in rheumatology: speaker representation at annual conferences’ by Monga et al’ by Colunga-Pedraza et al
Kanika Monga, Jean Liew

Annals of the Rheumatic Diseases Aug 2020, annrheumdis-2020-218630; DOI: 10.1136/annrheumdis-2020-218630
Response to: ‘Correspondence to ‘Associations of regular glucosamine use with all-cause and cause-specific mortality: a large prospective cohort study’ by Li et al’ by Yueh et al
Zhi-Hao Li, Wen-Fang Zhong, Qing-Mei Huang, Xi-Ru Zhang, Chen Mao

Annals of the Rheumatic Diseases Aug 2020, annrheumdis-2020-218659; DOI: 10.1136/annrheumdis-2020-218659
Correspondence to ‘Associations of regular glucosamine use with all-cause and cause-specific mortality: a large prospective cohort study’ by Li et al
Hann-Ziong Yueh, Chih-Jung Yeh, James Cheng-Chung Wei

Annals of the Rheumatic Diseases Aug 2020, annrheumdis-2020-218486; DOI: 10.1136/annrheumdis-2020-218486
Personal attributes as determinants of timely care in rheumatoid arthritis
G H Esselens, A De Brabander, L Ovaere, G De Brabanter, P Moons, R Westhovens

Annals of the Rheumatic Diseases Jul 2006, 65 (7) 967-968; DOI: 10.1136/ard.2005.046888

Main menu

health care

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

health care

Pages